Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMS pharmacodynamic evaluation of brexanolone in healthy male volunteers
NL-OMON60712Phase 1Completed
- Sponsor
- Sage Therapeutics
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of brexanolone (3 arms), sponsored by Sage Therapeutics. Primary endpoint: Change from baseline in TMS-MEP amplitude at T1. Started May 2023; status: completed.
02
Drugs
brexanolone
Beyond the preview
Go deeper on NL-OMON60712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60712.